Tolerability of Antiandrogens in the Treatment of Prostate Cancer

Author： Fourcade R.-O.   McLeod D.  

Publisher： Ashgate Publishing Ltd

ISSN： 1561-0950

Source： UroOncology, Vol.4, Iss.1, 2004-03, pp. : 5-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-steroidal anti-androgens in prostate cancer - current treatment practice

By Han M.   Nelson J.B.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 443-449

Informa Healthcare

Access to resources Recommend Favorite

Advancements in Non-steroidal Antiandrogens as Potential Therapeutic Agents for the Treatment of Prostate Cancer

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 7, 2016-05 ,pp. : 531-546

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives on designs of antiandrogens for prostate cancer

By EstÉbanez-PerpiñÁ Eva   Jouravel Natalia   Fletterick Robert J  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1341-1355

Informa Healthcare

Access to resources Recommend Favorite

Antiandrogens in Prostate Cancer Endocrine Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 5, 2004-08 ,pp. : 455-461

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer

By Mahler C.   Verhelst J.   Denis L.  

Clinical Pharmacokinetics, Vol. 34, Iss. 5, 1998-05 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite